Keywords: emea, clears, rasilez, high, blood, pressure, swiss

EMEA clears Rasilez for high blood pressure

Article | 03 September 2007

Swiss drug major Novartis says it has received European Medicines Agency (EMEA) approval for its antihypertensive Rasilez (aliskiren). The drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Novartis

Go to company listing

Related Drugs

Aliskiren Tablets

Tekturna

Go to drug listing